Apollo Therapeutics
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
50-60 Station Rd, Cambridge, Cambridgesh...Phone Number
+44 1438906842Website
www.apollotx.comRevenue
$16.1 MillionIndustry
About Apollo Therapeutics
Apollo Therapeutics Org Chart
Director, Program & Portfolio Strategy
Is Apollo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Apollo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Apollo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Apollo Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Apollo Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Apollo Therapeutics
Earning: See what the market has to say on Apollo Therapeutics recently announced quarterly report
Click to see if Apollo Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Apollo Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Apollo Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Apollo Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Apollo Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Apollo Therapeutics.
Apollo Therapeutics financials insights
Gather financial insights about Apollo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Unspecified
$145M
Series C
$226.5M
Series C
$33.5M
Apollo Therapeutics Tech Stack
A closer look at the technologies used by Apollo Therapeutics
Most Recent Scoops
Top Business Services Companies
Frequently Asked Questions Regarding Apollo Therapeutics
Apollo Therapeutics is a unique collaboration between three global pharmaceutical companies (AstraZeneca UK Limited, Glaxo Group Limited and Johnson & Johnson Innovation-JJDC, Inc.) and the technology transfer offices (TTOs) responsible for commercialising the research from Imperial College London, IP Group, UCL (University College London) and the... Read More